As oncology patient navigation leaders, we knew it before the start of the COVID-19 pandemic. Sadly, the pandemic spotlighted the longstanding health inequities that have existed systemically in the United States and gave impetus to highlight it—the fact that patient navigation is an evidence-based intervention that effectively addresses disparities in cancer care.
CLL’s unique properties may lead to providers and patients conceptualizing the prognosis differently. These findings present new information about the needs of people with CLL, with potentially transferable implications for people with other chronic illnesses. Information should be shared with providers about how to discuss a CLL prognosis sensitively.
More than 1.6 million people are diagnosed with cancer each year. Despite the different treatment options available for cancer, many individuals refuse treatment for various reasons. However, little is known about the cumulative group of individuals who refuse treatment.
Cancer-related financial hardship is linked to poor health outcomes and early mortality. Oncology financial advocacy (OFA) aims to prevent cancer-related financial hardship in oncology settings by assessing patients’ needs and connecting them to available financial resources. Despite promising evidence, OFA remains underutilized.
Fox Chase Cancer Center (FCCC) in collaboration with AONN+ conducted a pilot study to evaluate patient efficacy, provider feedback, and implementation of CAPE Lung using an implementation science framework in diverse cancer settings.